Stock Earnings

Question 1

Telix Pharmaceuticals Ltdの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Telix Pharmaceuticals Ltdの総資産は$983で、純profitは$32です。

Question 2

TLPPFの主要な財務比率は何ですか？

Accepted Answer

Telix Pharmaceuticals Ltdの流動比率は1.6、純利益率は6.31、1株当たり売上高は$1.46です。

Question 3

Telix Pharmaceuticals Ltdの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Telix Pharmaceuticals Ltd largest revenue segment is Precision Medicine, at a revenue of 771,106,000 in the most earnings release.For geography, United States is the primary market for Telix Pharmaceuticals Ltd, at a revenue of 762,308,000.

Question 4

Telix Pharmaceuticals Ltdは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Telix Pharmaceuticals Ltdの純profitは$32です。

Question 5

Telix Pharmaceuticals Ltdに負債はありますか？

Accepted Answer

yes、Telix Pharmaceuticals Ltdの負債は614です。

Question 6

Telix Pharmaceuticals Ltdの発行済株式数は何株ですか？

Accepted Answer

Telix Pharmaceuticals Ltdの総発行済株式数は334.72株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	662	507	325	103	7	5
Revenue Growth (YoY)	27%	56%	216%	1,371%	40%	67%
Cost of Revenue	304	194	122	42	2	2
Gross Profit	357	313	203	61	5	3
Selling, General & Admin	168	128	86	56	46	24
Research & Development	153	126	83	52	34	23
Operating Expenses	329	262	192	120	81	38
Other Non Operating Income (Expenses)	-26	-19	-8	-4	-5	0
Pretax Income	9	36	2	-63	-80	-47
Income Tax Expense	-1	3	-1	3	0	-3
Net Income	10	32	3	-67	-80	-44
Net Income Growth	-74%	967%	-104%	-16%	82%	63%
Shares Outstanding (Diluted)	337.2	345.18	323.71	310.64	282.2	257.27
Shares Change (YoY)	3%	7%	4%	10%	10%	10%
EPS (Diluted)	0.02	0.09	0.01	-0.21	-0.28	-0.17
EPS Growth	-75%	802%	-105%	-24%	64%	46%
Free Cash Flow	-23	-3	8	-50	-60	1
Free Cash Flow Per Share	-0.06	0	0.02	-0.16	-0.21	0
Gross Margin	53.92%	61.73%	62.46%	59.22%	71.42%	60%
Operating Margin	4.07%	10.05%	3.38%	-56.31%	-1,085.71%	-700%
Profit Margin	1.51%	6.31%	0.92%	-65.04%	-1,142.85%	-880%
Free Cash Flow Margin	-3.47%	-0.59%	2.46%	-48.54%	-857.14%	20%
EBITDA	--	--	--	-53	-71	-31
EBITDA Margin	--	--	--	-51.45%	-1,014.28%	-620%
D&A For EBITDA	--	--	--	5	5	4
EBIT	27	51	11	-58	-76	-35
EBIT Margin	4.07%	10.05%	3.38%	-56.31%	-1,085.71%	-700%
Effective Tax Rate	-11.11%	8.33%	-50%	-4.76%	0%	6.38%

Telix Pharmaceuticals Ltd (TLPPF) Price

TLPPF Stock Price Chart

TLPPF Income

Follow-Up Questions